Sensus Healthcare, Inc.
Sensus Healthcare, Inc. (SRTS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
srts · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Sensus Healthcare, Inc.You SRTS | $44M | N/A | — | — |
 Baird Medical Investment Holdings Limited BDMD | $52M | N/A | — | -$0.98 |
 Cytosorbents Corporation CTSO | $27M | N/A | — | -$0.13 |
 IceCure Medical Ltd ICCM | $8M | N/A | — | -$7.10 |
 Century Therapeutics, Inc. IPSC | $189M | N/A | — | -$0.11 |
 Karyopharm Therapeutics Inc. KPTI | $198M | N/A | — | -$17.93 |
 Spectral AI, Inc. MDAI | $61M | N/A | — | -$0.29 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Sensus Healthcare, Inc. (SRTS) measures how much investors pay for each dollar of the company's trailing earnings. SRTS's current PE ratio of N/A is calculated by dividing its stock price of $2.69 by its TTM earnings per share of —.
Frequently asked questions
SRTS pe ratio · 6 questionsSRTS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.69 and TTM EPS of —. Data sourced from Financial Modeling Prep via SRTS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Sensus Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09